Skip to main content
Log in

Lipide: Diagnostik und Therapie bei Diabetes mellitus Typ 2

Lipids: diagnosis and therapy in type 2 diabetes

  • leitlinien für die praxis
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Hyper- and Dyslipidemia contribute to cardiovascular morbidity and mortality in diabetic patients. Pharmacological therapy with statins has convincingly shown to reduce cardiovascular risk in diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the use of lipid-lowering drugs in diabetic patients according to current scientific evidence.

Zusammenfassung

Hyper- und Dyslipidämie tragen zur kardiovaskulären Morbidität und Mortalität diabetischer Patienten bei. Überzeugende Daten zeigen, dass durch die medikamentöse Therapie mit Statinen das kardiovaskuläre Risiko von Diabetikern senken kann. Der vorliegende Artikel stellt die Behandlungsvorschläge der österreichischen Diabetesgesellschaft zum Einsatz lipidsenkender Medikamente dar.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Notes

  1. wie einer Mikroalbuminurie

Literatur

  1. The Task Force for the Management of Dyslipidemias. ESC/EAS Guidelines for the management of dyslipidemias. Eur Herat J. 2011;32:1769–1818.

    Article  Google Scholar 

  2. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 trials of statins. Lancet 2005;366:1267–78.

    Article  PubMed  CAS  Google Scholar 

  3. Cholesterol Treatment Trialists Collaborators. Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008;371:117–25.

    Article  Google Scholar 

  4. Cholesterol Treatment Trialists Collaborators. The effect of lowering LDL cholesterol with statin therapy in people at low risk of vascular diesease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581–90.

    Google Scholar 

  5. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999;341:410–8.

    Article  PubMed  CAS  Google Scholar 

  6. Keach A, Simmes RJ, Barter B, Best J, Scott R, Taskinen MR, et al., Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type-2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005;366:1849–61.

    Article  Google Scholar 

  7. The ACCORD Study Group. Effects of combination lipid therapy in Type 2 diabetes mellitus. N Engl J Med. 2010;362:1563–74.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas C. Wascher.

Additional information

Für den Ausschuss Leitlinien

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wascher, T., Paulweber, B., Toplak, H. et al. Lipide: Diagnostik und Therapie bei Diabetes mellitus Typ 2. Wien Klin Wochenschr 124 (Suppl 2), 28–30 (2012). https://doi.org/10.1007/s00508-012-0273-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-012-0273-3

Keywords

Schlüsselwörter

Navigation